Surgical treatment of bronchial carcinoid tumors: A single-center experience
| Autor: | Spencer Marcantonio Camargo, Ana Luiza Schneider Moreira, Cristiano Feijó Andrade, Leonardo Signori, Tiago N. Machuca, José da Silva Moreira, Paulo Francisco Guerreiro Cardoso, José de Jesus Peixoto Camargo, José Carlos Felicetti |
|---|---|
| Rok vydání: | 2010 |
| Předmět: |
Adult
Male Pulmonary and Respiratory Medicine Cancer Research medicine.medical_specialty Adolescent Carcinoid tumors Pulmonary Surgical Procedures Carcinoid Tumor Chest pain Single Center Bronchoscopy Risk Factors Bronchial neoplasm Fiber Optic Technology Humans Medicine Aged Neoplasm Staging Aged 80 and over medicine.diagnostic_test business.industry Pleural empyema Bronchial Neoplasms Respiratory disease Middle Aged Prognosis medicine.disease Survival Analysis Surgery Treatment Outcome Oncology Female medicine.symptom business Follow-Up Studies |
| Zdroj: | Lung Cancer. 70:158-162 |
| ISSN: | 0169-5002 |
| Popis: | Background Bronchial carcinoid is an infrequent neoplasm with a neuroendocrine differentiation. Surgical treatment is the gold standard therapy, with procedures varying from sublobar resections to complex lung sparing broncoplastic procedures. This study evaluates the results of surgical treatment of bronchial carcinoids and its prognostic factors. Patients and methods Retrospective review of 126 consecutive patients who underwent surgical treatment for bronchial carcinoid tumors between December 1974 and July 2007. Results There were 70 females (55%) and the mean age was 46 years, ranging from 17 to 81 years. Upon clinical presentation, 38 patients (30%) have had recurrent respiratory tract infection, 31 (24%) cough, 16 (12%) chest pain and 25 (20%) were asymptomatic. Preoperative bronchoscopic diagnosis was obtained in 74 cases (58.7%). The procedures performed were: 19 sublobar resections (14,9%), 58 lobectomies (46%), 8 bilobectomies (6.3%), 6 pneumonectomies (4.7%), 2 sleeve segmentectomies (1.5%), 26 sleeve lobectomies (20.6%) and 9 bronchoplastic procedures without lung resection (7.1%). Operative mortality was 1.5% (n = 2) and morbidity was 25.8% (n = 32), including 12 respiratory tract infections and 4 reinterventions due to bleeding (3) and pleural empyema (1). Among the 112 patients available for follow-up, the overall survival at 3, 5 and 10 years was 89.2%, 85.5% and 79.8%, respectively. Five and 10-year survival for typical and atypical carcinoids were 91, 89% and 56, 47%, respectively. Overall disease-free survival at 5 years was 91.9% Statistical analysis showed that overall disease-free survival correlated with histology – typical vs. atypical – (p = 0.04) and stage (p = 0.02). Conclusion Surgery provides safe and adequate treatment to bronchial carcinoid tumors. Histology and stage were the main prognostic factors. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect